Member Info for JimiHendrix

JC said they were finalising agreements with some really good FDA partners who will help get AIHL through the FDA process faster and much cheaper than would usually be expected. He said he expects to update us on this by end of January.

He also said something is going to happen in January regarding NICE and AIHL. Plus stroke marker guidance report published this month hopefully.

Another big one is specialist commission which will allow us to circumvent NICE and immediately begin full rollout to the NHS. This is expected to happen sooner rather than later.

With the news expected this month, there’s an opportunity for 40-100% profit from this level imo. Sucker if you miss it imo lol. Good luck all.

I expect we’ll get some more of the expected positive news before any funding. After all the amount they’ll need will depend on the deal with the partners, so I expect partner news to come first, as well as NICE update for stroke marker test and special commissioning for AIHL.

Delayed RF sell, that’s what was holding it back. It should move up now if the buying continues.

JC was confident that they will receive specialist commissioning for the NHS, this will rapidly speed up adoption throughout the NHS.

Should hear an update very soon on the FDA partners, within the next couple of weeks is my guess. Plus NICE update this month aswell.

That’s exactly what often happens when a placing is coming or background seller.

650,000 sell from I’m guessing RF. I’m surprised they were allowed to do that with such low trading volume today.

The placing will be for FDA submission.

CPT PLA Code 0433U has been issued to Oxford BioDynamics for insurance reimbursement under Medicare, Medicaid and private payors

The CPT PLA Application for PSE was filed on July 5 and granted by the American Medical Association (AMA) less than 3 months after filing

New code available for use from 1 January 2024 for insurance reimbursement (Medicare, Medicaid or private payers)

A unique reimbursement code aids the billing process and reinforces physician confidence

Lovely to see the rise but slightly disappointed that these are only the initial orders for the distributors so that they have some stock to demo and try to sell, I was hoping for an actual order from an EU hospital but looks like we’re not at that stage yet.

A positive step in the right direction though.

Yes it did :)

I don’t think it’ll take much to see this back over 10p before news.

It was actually quite difficult to buy at times today, I managed to get a few buys in but often they were rejected, particularly after a small wave of buying.

The big buys earlier did push the price up but then volume tailed off so gradually they reduced the asking price until it was under 8p.

Not a big deal either way :)

A few of those red trades at the end under 8p were buys, I checked the live quotes all afternoon so know. The live sell quote was 7.75 so the 300k was a buy.

That was a 300k buy there on close, I was getting buy quotes around 7.8 / 7.9 for the past 30 mins so had to be.

I would imagine we will see a steady increase, given the expected news. Several of those news items have the potential to really put a rocket under the share price.

I’m expecting an update on those orders at the end of the month or early January.

How about a potential £320 million market :)

Or how about FDA approval possibly within 6 months, or when we receive specialist commissioning we have immediate nationwide rollout to the NHS £8m UK market.

Tons of other news too… EU orders starting this month, NICE stroke marker recommendation, FDA partners and more!

Yes looking promising. Some magic coming I think!

Just Riverfort again. Hopefully it’ll get back above 10p going into the end of the year / beginning of next in anticipation of the various news items.